Name | Number of supported studies | Average coverage | |
---|---|---|---|
enterocyte | 6 studies | 39% ± 16% | |
hepatocyte | 5 studies | 65% ± 20% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
liver | 4 studies | 29% ± 10% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
liver | 100% | 55255.39 | 226 / 226 | 84% | 855.67 | 342 / 406 |
adrenal gland | 92% | 386.78 | 237 / 258 | 19% | 3.37 | 43 / 230 |
pancreas | 82% | 2567.63 | 268 / 328 | 22% | 2.88 | 39 / 178 |
intestine | 61% | 6031.04 | 585 / 966 | 17% | 2.35 | 89 / 527 |
kidney | 64% | 44.51 | 57 / 89 | 13% | 1.35 | 113 / 901 |
skin | 72% | 133.54 | 1308 / 1809 | 2% | 0.14 | 11 / 472 |
esophagus | 44% | 25.54 | 639 / 1445 | 11% | 0.91 | 21 / 183 |
breast | 51% | 33.56 | 234 / 459 | 1% | 0.03 | 12 / 1118 |
stomach | 26% | 14.67 | 95 / 359 | 22% | 1.57 | 63 / 286 |
muscle | 48% | 148.69 | 388 / 803 | 0% | 0 | 0 / 0 |
adipose | 43% | 21.92 | 514 / 1204 | 0% | 0 | 0 / 0 |
ovary | 38% | 10.84 | 69 / 180 | 1% | 0.02 | 5 / 430 |
peripheral blood | 37% | 123.03 | 341 / 929 | 0% | 0 | 0 / 0 |
prostate | 27% | 6.50 | 65 / 245 | 2% | 0.09 | 8 / 502 |
lung | 22% | 8.45 | 126 / 578 | 5% | 0.89 | 63 / 1155 |
uterus | 19% | 6.58 | 33 / 170 | 3% | 0.12 | 16 / 459 |
thymus | 15% | 4.13 | 97 / 653 | 5% | 0.67 | 33 / 605 |
brain | 18% | 6.37 | 464 / 2642 | 1% | 0.03 | 7 / 705 |
spleen | 17% | 12.83 | 40 / 241 | 0% | 0 | 0 / 0 |
heart | 12% | 5.04 | 104 / 861 | 0% | 0 | 0 / 0 |
blood vessel | 12% | 4.81 | 161 / 1335 | 0% | 0 | 0 / 0 |
bladder | 5% | 1.10 | 1 / 21 | 5% | 0.18 | 25 / 504 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 45 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0006805 | Biological process | xenobiotic metabolic process |
GO_0008209 | Biological process | androgen metabolic process |
GO_0036378 | Biological process | calcitriol biosynthetic process from calciol |
GO_0008203 | Biological process | cholesterol metabolic process |
GO_0009822 | Biological process | alkaloid catabolic process |
GO_0016098 | Biological process | monoterpenoid metabolic process |
GO_0042369 | Biological process | vitamin D catabolic process |
GO_0042573 | Biological process | retinoic acid metabolic process |
GO_0042359 | Biological process | vitamin D metabolic process |
GO_0042178 | Biological process | xenobiotic catabolic process |
GO_0046222 | Biological process | aflatoxin metabolic process |
GO_0042572 | Biological process | retinol metabolic process |
GO_0002933 | Biological process | lipid hydroxylation |
GO_0008210 | Biological process | estrogen metabolic process |
GO_0042759 | Biological process | long-chain fatty acid biosynthetic process |
GO_0006706 | Biological process | steroid catabolic process |
GO_0070989 | Biological process | oxidative demethylation |
GO_0006629 | Biological process | lipid metabolic process |
GO_0008202 | Biological process | steroid metabolic process |
GO_0005789 | Cellular component | endoplasmic reticulum membrane |
GO_0005737 | Cellular component | cytoplasm |
GO_0043231 | Cellular component | intracellular membrane-bounded organelle |
GO_0019899 | Molecular function | enzyme binding |
GO_0070330 | Molecular function | aromatase activity |
GO_0062189 | Molecular function | anandamide 14,15 epoxidase activity |
GO_0101020 | Molecular function | estrogen 16-alpha-hydroxylase activity |
GO_0102320 | Molecular function | 1,8-cineole 2-exo-monooxygenase activity |
GO_0019825 | Molecular function | oxygen binding |
GO_0016491 | Molecular function | oxidoreductase activity |
GO_0004497 | Molecular function | monooxygenase activity |
GO_0005506 | Molecular function | iron ion binding |
GO_0008401 | Molecular function | retinoic acid 4-hydroxylase activity |
GO_0020037 | Molecular function | heme binding |
GO_0034875 | Molecular function | caffeine oxidase activity |
GO_0062187 | Molecular function | anandamide 8,9 epoxidase activity |
GO_0005496 | Molecular function | steroid binding |
GO_0050649 | Molecular function | testosterone 6-beta-hydroxylase activity |
GO_0062181 | Molecular function | 1-alpha,25-dihydroxyvitamin D3 23-hydroxylase activity |
GO_0030343 | Molecular function | vitamin D3 25-hydroxylase activity |
GO_0008395 | Molecular function | steroid hydroxylase activity |
GO_0050591 | Molecular function | quinine 3-monooxygenase activity |
GO_0005515 | Molecular function | protein binding |
GO_0062188 | Molecular function | anandamide 11,12 epoxidase activity |
GO_0070576 | Molecular function | vitamin D 24-hydroxylase activity |
GO_0101021 | Molecular function | estrogen 2-hydroxylase activity |
Gene name | CYP3A4 |
Protein name | Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55) Cytochrome P450 family 3 subfamily A member 4 Cytochrome P450 3A (EC 1.14.14.-) |
Synonyms | CYP3A3 tcag7.603 hCG_17094 |
Description | FUNCTION: A cytochrome P450 monooxygenase involved in the metabolism of sterols, steroid hormones, retinoids and fatty acids . Mechanistically, uses molecular oxygen inserting one oxygen atom into a substrate, and reducing the second into a water molecule, with two electrons provided by NADPH via cytochrome P450 reductase (NADPH--hemoprotein reductase). Catalyzes the hydroxylation of carbon-hydrogen bonds . Exhibits high catalytic activity for the formation of hydroxyestrogens from estrone (E1) and 17beta-estradiol (E2), namely 2-hydroxy E1 and E2, as well as D-ring hydroxylated E1 and E2 at the C-16 position . Plays a role in the metabolism of androgens, particularly in oxidative deactivation of testosterone . Metabolizes testosterone to less biologically active 2beta- and 6beta-hydroxytestosterones . Contributes to the formation of hydroxycholesterols (oxysterols), particularly A-ring hydroxylated cholesterol at the C-4beta position, and side chain hydroxylated cholesterol at the C-25 position, likely contributing to cholesterol degradation and bile acid biosynthesis . Catalyzes bisallylic hydroxylation of polyunsaturated fatty acids (PUFA) . Catalyzes the epoxidation of double bonds of PUFA with a preference for the last double bond . Metabolizes endocannabinoid arachidonoylethanolamide (anandamide) to 8,9-, 11,12-, and 14,15-epoxyeicosatrienoic acid ethanolamides (EpETrE-EAs), potentially modulating endocannabinoid system signaling . Plays a role in the metabolism of retinoids. Displays high catalytic activity for oxidation of all-trans-retinol to all-trans-retinal, a rate-limiting step for the biosynthesis of all-trans-retinoic acid (atRA) . Further metabolizes atRA toward 4-hydroxyretinoate and may play a role in hepatic atRA clearance . Responsible for oxidative metabolism of xenobiotics. Acts as a 2-exo-monooxygenase for plant lipid 1,8-cineole (eucalyptol) . Metabolizes the majority of the administered drugs. Catalyzes sulfoxidation of the anthelmintics albendazole and fenbendazole . Hydroxylates antimalarial drug quinine . Acts as a 1,4-cineole 2-exo-monooxygenase . Also involved in vitamin D catabolism and calcium homeostasis. Catalyzes the inactivation of the active hormone calcitriol (1-alpha,25-dihydroxyvitamin D(3)) . . FUNCTION: Cytochromes P450 are a group of heme-thiolate monooxygenases. In liver microsomes, this enzyme is involved in an NADPH-dependent electron transport pathway. It oxidizes a variety of structurally unrelated compounds, including steroids, fatty acids, and xenobiotics. . FUNCTION: Cytochromes P450 are a group of heme-thiolate monooxygenases. In liver microsomes, this enzyme is involved in an NADPH-dependent electron transport pathway. It oxidizes a variety of structurally unrelated compounds, including steroids, fatty acids, and xenobiotics. . FUNCTION: Cytochromes P450 are a group of heme-thiolate monooxygenases. In liver microsomes, this enzyme is involved in an NADPH-dependent electron transport pathway. It oxidizes a variety of structurally unrelated compounds, including steroids, fatty acids, and xenobiotics. . |
Accessions | A0A499FJM4 P08684 Q7Z448 ENST00000651514.1 ENST00000415003.1 ENST00000336411.7 Q6GRK0 ENST00000652018.1 E7EVM8 C9JBD2 ENST00000354593.6 A0A494C0W7 |